Loading clinical trials...
Loading clinical trials...
The main purpose of the study is to evaluate safety and efficacy of Alkotinib capsule in patients with ALK-positive non-small cell lung cancer previously treated with crizotinib.While exploring the re...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
NCT06361589 · ALK-positive Non-small Cell Lung Cancer, Real World Study
NCT06410040 · ALK-positive Non-small Cell Lung Cancer, Brain Metastases, and more
NCT06834074 · Non Small Cell Lung Cancer, ALK-positive Non-small Cell Lung Cancer (NSCLC)
NCT06785584 · ALK-positive Advanced NSCLC, ALK-positive Non-small Cell Lung Cancer (NSCLC), and more
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions